Advertisement

Topics

Companies Related to "Liver Transplant Patients With Alcoholic Liver Disease" [Most Relevant Company Matches] RSS

04:09 EDT 22nd August 2018 | BioPortfolio

Here are the most relevant search results for "Liver Transplant Patients With Alcoholic Liver Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Liver Transplant Patients With Alcoholic Liver Disease" Companies 1–25 of 5,600+

Extremely Relevant

American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.


Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...

ORIDIS Biomed GmbH

ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed has built a potent drug discovery and development organization based on its extensive scientific and clinical expertise in the area of liver disease, its proprietary TISSOMICS™ research engine, an...


Ambys Medicines

Ambys Medicines is a biotechnology company focused on discovering and developing transformative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet th...

YES

YES is a grassroots organization that provides cancer patients with support, resources, options, education and hope in their fight against liver tumors. It is made up of survivors who have undergone treatment for primary hepatocellular (liver) cancer or liver metastases (cancer that has spread to the liver) from other cancers. For more information ...

AlphaNet, Inc.

Alpha-1 Antitrypsin Deficiency is one of North America’s most prevalent, potentially lethal hereditary disorders. Discovered in 1963, Alpha-1 can cause life-threatening lung and/or liver disease. It is a leading genetic killer of adults in North America and a leading cause of liver transplants in children. It is estimated that between 10,000 and 15,000 ...

Jecure Therapeutics

Jecure is focused on the discovery of novel therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. With operations in the biotech hub of San Diego, Califo...

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, heart surgery, gamma knife surgery (radiosurgery), paediatric care, craniofacial surgery and urology.

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

AlphaNet

Alpha-1 Antitrypsin Deficiency is a leading genetic killer of adults and a leading cause of liver transplants in children. It is estimated that 20 million Americans are undetected carriers of the Alpha-1 gene and may be at risk for lung and/or liver disease. Only 10 percent of the estimated 100,000 with severe deficiency of Alpha-1 have been diagnosed.

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide clinicians with a comprehensive, 24–48 hour service for genotyping, qualitation and quantification of both the Hepatitis C (HCV) and Hepatitis B (HBV) viruses.Founded in 2003 by liver disease special...

Texas Children's Hospital

Texas Children's Hospital runs an active transplantation program in heart, lungs, liver, kidney and bone morrow for pediatric patients. In 1984, Dr. Denton A. Cooley performed the first pediatric heart transplant on a 9-month-old female patient. She lived to be 13 years old. Since that time, the heart transplant program has grown into one of the largest and most successful program of its kind in t...

Sirtex Medical Inc.

Sirtex Medical Limited (ASX:SRX) is an Australian-based global healthcare business working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 50,000 doses have been supplied to treat patients with liver cancer at more than 800 medical...

The Pelican Cancer Foundation

The Pelican Cancer Foundation is a unique charity, dedicated exclusively to curing cancer patients by advancing the latest techniques of precision surgery.The Charity derives its name from the words Pelvic and Liver Cancer.Formed in 2000, it was based around the pioneering work ofProfessor ‘Bill’ Heald OBE, Mr Brendan Moran and colleagues at the North Hampshire Hospital in bowel cancer surgery...

Promethera Biosciences

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. We are a team of international experts...

Promethera Biosciences SA

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. We are a team of international experts...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

Galectin Therapeutics, Inc.

Galectin Therapeutics (OTC: GALT) is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the Company’s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to...

Exalenz Bioscience, Inc.

Exalenz Bioscience develops and markets medical equipment for breath testing for the purposes of diagnosis and management of digestive system and liver conditions. The company sells the BreathID® System together with proprietary disposable test kits. The BreathID® System has been proven effective for clinical use in the task of identifying the presen...

Relevant

HµREL Corporation

HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise sponsorship firm (www.athenacapital.net). HµREL is presently inaugurating a Joint Scientific Collaboration (“JSC”), through which a group of global pharmaceutical and consumer products firms will...

Amphioxus Cell Technologies

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® product achieves this goal by combining a highly developed human liver cell line with meaningful, high throughput assays.

Ocera Therapeutics, Inc.

Ocera Therapeutics, based in San Diego, California, USA, is a privately held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat acute and chronic liver diseases and a broad range of gastrointestinal disorders. In addition to AST-120, Ocera is developing OCR-002, an ammonia detoxification agent, for the treatment of hospitalized patients wit...

SangStat Medical Corporation

SangStat, The Transplant Company(R), is a specialty pharmaceutical company applying a disease management approach to improve the outcome of organ transplantation. The Company's devices, drugs and services form a family of products that address the needs of patients in each stage of transplant care from pre-transplant monitoring to lifetime post-transplant care. SangStat's product pipeline is a com...

Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the companyâ€...


More From BioPortfolio on "Liver Transplant Patients With Alcoholic Liver Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks